The NanoBase™ Architecture

In 1949, chemist William Griffin gave the industry a single number: the Hydrophile-Lipophile Balance, HLB. Match an emulsifier’s HLB value to an oil’s required HLB and the emulsion holds together. That was a reasonable dial for its era, and it was never anything more than that: a way to keep one phase from separating from another, not a design for delivery. Three-quarters of a century later, HLB is still the physics under almost everything on the shelf marketed as “next-generation.” Rename the surfactant blend, raise the actives count, call it a serum instead of a lotion: underneath, it is still one balance number, tuned so one system does not fall apart.

A stability fix wearing a delivery system’s clothing: the ceiling most topical formulation has been building against for seventy-five years without ever naming it.

When you formulate on a modern architecture like NanoBase™, the question changes entirely. Not “what single balance keeps this from separating?” but “what if three distinct nano-domains were engineered to coexist, on purpose, inside one lecithin-based, pourable system?” That shift, not a faster HLB, is the entire idea. We call it TDA Logic, and this page is the architecture it produces: an engineered, DLS-characterized tri-domain architecture built as a successor to the HLB emulsion chassis for topical formulation.

These three are not averaged into one morphology. They coexist as separate compartments, each doing the job it is shaped for. If HLB Logic is a single thermostat for one room, TDA Logic is a building with three purpose-built rooms, each conditioned for a different occupant, all sharing one lecithin-based structural chassis.

A fair question follows at once: if three different nano-populations share one liquid, why do they not merge, ripen, or crash out into separate layers the way an under-engineered system would? The answer is the electrostatic wall, the principle at the core of the Architecture: a barrier we reason about through DLVO theory (Derjaguin, Landau, Verwey, Overbeek), the classical account of colloidal stability. DLVO is cited for the established framework; these researchers have not evaluated NanoBase™.

In DLVO terms, two approaching particles feel competing forces: an attraction pulling them together and an electrostatic repulsion pushing them apart. Engineer the interfacial charge so repulsion dominates across the distances that matter, and you raise an energy barrier, a wall, the domains cannot easily climb. That wall is the design intent for keeping the tri-domain population physically stable and the domains from coalescing into one: three morphologies share one continuous phase without collapsing into it, by design and not by luck.

Two points of discipline belong here. First, the electrostatic wall is a design principle, the intent we build toward, not a certificate: we do not publish it as a measured assay or a reported charge value. Second, the physics is conventional. Nothing in NanoBase™ bends DLVO theory or thermodynamics; we apply those laws deliberately, toward an outcome the field rarely asked of them.

Every batch is characterized by dynamic light scattering, DLS, the workhorse method for sizing sub-micron colloids: it watches how particles scatter light as they diffuse and reconstructs a size distribution from that motion. We read the Architecture with multi-angle DLS, which resolves distinct populations more reliably than a single fixed angle, because a genuinely multimodal sample behaves differently from several angles in a way one narrow population does not.

This is where a tri-domain system parts ways with a conventional one. Legacy carriers are engineered toward a single narrow mode: one population, one peak, as tight as the process allows. A tri-domain architecture is not trying to be one peak. Because three engineered populations coexist, the distribution resolves as a multimodal signature, more than one mode, each consistent with a designed domain rather than a single spike forced onto one size.

Every batch is DLS-characterized against the ~185 nm design target, with the multimodal distribution a tri-domain design is expected to show, not the single narrow peak legacy QC was trained to demand. Read through an old lens, a broad distribution looks like polydispersity to be scrubbed out, a batch that failed to converge on one size. Read through TDA Logic, it is the design doing its job: three deliberately different domains should not collapse into one narrow peak. DLS resolves a reproducible multimodal size distribution consistent with the tri-domain design. It reports hydrodynamic size, not shape, so direct morphological confirmation such as cryo-TEM or SAXS remains future validation work, not data we hold today.

NanoBase™ does not contest the thermodynamics. It engineers within the kinetic-stability paradigm: a deliberately co-populated, electrostatically stabilized architecture in which nanocolloidal, nanoliposomal, and nanomicellar domains coexist by design, characterized by multi-angle DLS. What the field framed as a defect, coexisting morphologies, NanoBase™ makes the architecture.

Two established results explain why that coexistence can be stable rather than a transient stop on the way to separating. Nanoemulsions are kinetically stable, not thermodynamically stable: they persist because of an engineered energy barrier, not because they sit at a system’s lowest-energy state (McClements 2012). That kinetic stability is itself describable as an activation barrier a system must climb before it can relax toward its thermodynamic endpoint (Gupta, Eral & Hatton 2016). The electrostatic wall described above is that barrier, designed so three domains can sit in long-lived states side by side rather than drifting toward each other. McClements and Gupta, Eral & Hatton are cited for the established framework; these authors have not evaluated NanoBase™.

None of this touches the packing-parameter law. Israelachvili, Mitchell & Ninham (1976) established that a given amphiphile system has one preferred equilibrium morphology, set by its packing parameter, and that law is not disproven or evaded here: within each domain, the lipid or surfactant populating it still assembles into the morphology its own packing parameter predicts. What NanoBase™ changes is the question asked of the whole system. Instead of forcing one bulk composition toward the single morphology its average packing parameter would favor, the Architecture deliberately co-populates three distinct, kinetically stabilized assemblies side by side in one chassis, each internally consistent with the law, none of them alone describing the whole.

Colloid science has a name for what happens when a system will not resolve to one morphology, and it is not a flattering one. In block-copolymer self-assembly specifically, multi-morphology coexistence has long been framed as a loss of processing control, an instability to engineer out (Doncom et al. 2017, Chem Soc Rev). That framing comes from the polymer self-assembly literature, not from any study of lecithin-based tri-domain chemistry, and we cite it to show how deep the old convention runs, not as evidence about NanoBase™ itself.

The coexistence the field spent decades suppressing is the outcome we engineer for, holding three populations open at once instead of collapsing them into one.

Read carefully, this is a claim about design intent, not a claim about physics and not a claim of proof. NanoBase™ is an engineered, DLS-characterized tri-domain architecture, read as a multimodal size distribution, not as three imaged domain shapes. We say the domains are engineered and DLS-characterized. We do not say they are visually confirmed, because DLS reports hydrodynamic size, not structure, and direct morphological confirmation, for example cryo-TEM or SAXS, is future validation work, not data we hold today. The rationale and characterization are set out in two preprints on Zenodo, the first preprint (February 2026) and the second preprint (August 2026). Both are preprints describing the Architecture, offered for technical scrutiny, not peer-reviewed endpoints.

NanoBase™ ships as a finished cosmetic raw material with its own INCI, manufactured by Pensive Beauty® from a boutique nanoscience lab and a 9,000 sq ft production facility, a modern replacement of an HLB base. On its own it is deliberately empty: an unloaded chassis, a leave-on aqueous architecture for intact skin, carrying no actives until a brand adds them. NanoBase™ is the Architecture a formula is built on, never the finished formula itself.

That top layer is where real production happens. A brand, or its contract manufacturer, takes the Architecture and loads its own actives by gentle, room-temperature mixing, letting each active partition toward the domain its chemistry prefers. The finished formula built on top of NanoBase™ is cold-processable and producible at any qualified contract manufacturer on standard cosmetic mixing equipment at room temperature. The nanoscience is already engineered into the chassis; the brand’s work is formulation, not colloid engineering from scratch.

Two commitments keep this page honest. First, characterization. DLS is the only assay we run on the Architecture, and we report only what it shows: a multimodal size signature against the ~185 nm design target, consistent with the designed domains. DLS is the only characterization assay we cite; other methods are named only as suggested future validation, never as results we hold. Our vocabulary is deposition, and we make no deposition claim until a study on finished formulas is published. We make no claims about what happens beneath the skin surface, and none about disease, structure, or function.

Second, rationale. Particle size is a design variable in the colloid literature, and we cite that literature for the framework only, never as a NanoBase™ result or as a head-to-head test against an HLB system. NanoBase™ itself carries no actives, so it is not clinically tested and makes no disease or structure-function claims. We characterize the Architecture; what actives do once a brand loads them is the brand’s to substantiate.

The quickest way to understand NanoBase™ is to design on it. For the logic behind the shift from HLB, read TDA Logic; for the direct comparison, see NanoBase™ vs HLB; to compare tuned variants of this same chassis, explore the NanoBase™ family; for full citations and preprint methods, visit research and evidence; and for exact definitions of every term on this page, see the glossary. To see how brands build finished formulas on top of the Architecture, meet our partners and the skincare formulation lab.